310 related articles for article (PubMed ID: 10743980)
1. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.
Kollar C; Schneider H; Waksman J; Krusinska E
Clin Ther; 2007 Jun; 29(6):1057-70. PubMed ID: 17692721
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
5. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
7. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials.
Kyriakidou KG; Rafailidis P; Matthaiou DK; Athanasiou S; Falagas ME
Clin Ther; 2008 Oct; 30(10):1859-68. PubMed ID: 19014841
[TBL] [Abstract][Full Text] [Related]
8. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
Boman G; Bäcker U; Larsson S; Melander B; Wåhlander L
Eur J Respir Dis; 1983 Aug; 64(6):405-15. PubMed ID: 6350033
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M; Möller A; Wassmer G; Brunkwall J
Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
Brocard H; Charpin J; Germouty J
Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Duong MH; MacKenzie TA; Malenka DJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
[TBL] [Abstract][Full Text] [Related]
12. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
[TBL] [Abstract][Full Text] [Related]
13. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
Rasmussen JB; Glennow C
Eur Respir J; 1988 Apr; 1(4):351-5. PubMed ID: 3294038
[TBL] [Abstract][Full Text] [Related]
14. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral N-acetylcysteine on mucus clearance.
Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review.
Stey C; Steurer J; Bachmann S; Medici TC; Tramèr MR
Eur Respir J; 2000 Aug; 16(2):253-62. PubMed ID: 10968500
[TBL] [Abstract][Full Text] [Related]
17. Effect of Orally Administered N-Acetylcysteine on Chronic Bronchitis: A Meta-analysis.
Wei J; Pang CS; Han J; Yan H
Adv Ther; 2019 Dec; 36(12):3356-3367. PubMed ID: 31598901
[TBL] [Abstract][Full Text] [Related]
18. Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
Ashworth A; Webb ST
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):303-8. PubMed ID: 20570977
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis.
Grandjean EM; Berthet PH; Ruffmann R; Leuenberger P
Pharmacol Res; 2000 Jul; 42(1):39-50. PubMed ID: 10860633
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the clinical use of intravenous and oral N-acetylcysteine in the treatment of acute acetaminophen poisoning in children: a retrospective review.
Blackford MG; Felter T; Gothard MD; Reed MD
Clin Ther; 2011 Sep; 33(9):1322-30. PubMed ID: 21890206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]